Managers / Q3 2019 · view latest →
JOHN G ULLMAN & ASSOCIATES INC
CIK 0000919530 · 51 EAST MARKET STREET, P O BOX 1424, CORNING, NY, 14830 · 6079363785
Summary
John G Ullman & Associates Inc reported $551M in U.S.-listed holdings across 144 positions for Q3 2019.
Its largest position, EMR, represents 7.6% of the portfolio.
Compared with Q2 2019, the fund opened 14 new positions and exited 18.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 71.6% · $394M
- Other · 20.5% · $113M
- ETP · 5.1% · $28M
- ADR · 2.7% · $15M
- Closed-End Fund · 0.0% · $132,000
Quarter-over-Quarter Changes full breakdown →
vs Q2 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| XRXXEROX CORP | NEW | +116.8K | 116.8K | +$3M | $3M |
| 4DHDANA INC | NEW | +179.8K | 179.8K | +$3M | $3M |
| ELANELANCO ANIMAL HEALTH INC | NEW | +90.8K | 90.8K | +$2M | $2M |
| ANETEURARISTA NETWORKS INC ANET | NEW | +9.8K | 9.8K | +$2M | $2M |
| HORIZON THERAPEUTICS PLC | NEW | +79.6K | 79.6K | +$2M | $2M |
| SKANSKA AB ORDF | NEW | +22.6K | 22.6K | +$458,000 | $458,000 |
| HLIOHELIOS TECHNOLOGIES INC | NEW | +9.1K | 9.1K | +$369,000 | $369,000 |
| ISHARES:NASDAQ BIOTECH | NEW | +2.9K | 2.9K | +$289,000 | $289,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2019
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $754M | 174 | May 6, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $750M | 179 | Feb 5, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $743M | 173 | Nov 5, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $674M | 174 | Jul 29, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $648M | 170 | May 6, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $680M | 172 | Feb 5, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $696M | 179 | Nov 8, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $655M | 179 | Aug 8, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $652M | 174 | May 6, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $630M | 169 | Jan 31, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $611M | 173 | Nov 1, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | under review | 177 | Aug 21, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $642,976 | 177 | May 5, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | under review | 169 | Feb 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $572M | 157 | Oct 19, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $623M | 157 | Jul 27, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $722M | 168 | Apr 29, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $727M | 162 | Jan 26, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $735M | 160 | Nov 2, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $768M | 156 | Jul 23, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $745M | 154 | Apr 22, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $645M | 152 | Feb 5, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $483M | 128 | Nov 6, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $410M | 109 | Jul 29, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $377M | 101 | Apr 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $581M | 142 | Jan 29, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $551M | 144 | Oct 21, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $569M | 148 | Aug 2, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $552M | 128 | Apr 30, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $496M | 129 | Jan 29, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.